Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

• मुख्य लेखकों: Alistair Ring (लेखक), Meghan Karuturi (लेखक), Emily Nash Smyth (लेखक), Tasneem Lokhandwala (लेखक), Kristin M. Sheffield (लेखक), Joanne Willey (लेखक), Orsolya Lunacsek (लेखक), Francisco Sapunar (लेखक), Zhanglin Lin Cui (लेखक), Anna D. Coutinho (लेखक), Sarah Rybowski (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...